---
title: "NAGE: Q2 2026 delivered $29.8M sales, $1M net income, and major telehealth and pharma launches"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294864217.md"
description: "Q2 2026 saw $29.8M in net sales, 23% DTC growth, and $1M net income, with strong gross margins and $66.7M in cash. Strategic launches in telehealth and pharmaceuticals, plus regulatory wins, position the company for future growth despite rising expenses and competitive pressures.Original document: Niagen Bioscience, Inc. [NAGE] SEC 8-K Current Report — Aug. 4 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-08-04T20:09:52.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294864217.md)
  - [en](https://longbridge.com/en/news/294864217.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294864217.md)
generator: "portal-rs"
---

# NAGE: Q2 2026 delivered $29.8M sales, $1M net income, and major telehealth and pharma launches

Q2 2026 saw $29.8M in net sales, 23% DTC growth, and $1M net income, with strong gross margins and $66.7M in cash. Strategic launches in telehealth and pharmaceuticals, plus regulatory wins, position the company for future growth despite rising expenses and competitive pressures.

Original document: Niagen Bioscience, Inc. \[NAGE\] SEC 8-K Current Report — Aug. 4 2026

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [NAGE.US](https://longbridge.com/en/quote/NAGE.US.md)

## Related News & Research

- [AI in Virtual Medical Assistant Market to Reach US$ 12.3 Bn by 2031, Growing at 36.5% CAGR, New Report by Wissen Research](https://longbridge.com/en/news/298618482.md)
- [4,000 Shares in Ligand Pharmaceuticals Incorporated $LGND Acquired by JW Asset Management LLC](https://longbridge.com/en/news/298374596.md)
- [EXCLUSIVE-TPG explores $5 billion sale of healthcare software company Lyric, sources say](https://longbridge.com/en/news/298497579.md)
- [CRMD: Strong revenue growth, pipeline expansion, and financial flexibility drive continued value creation](https://longbridge.com/en/news/298461323.md)
- [Anthem (NASDAQ:ANTX) Director Robin Shane Readnour Sells 6,100 Shares of Stock](https://longbridge.com/en/news/298381637.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**